Clinical Trial Update: Anesthesic Propofol and Remifentanil Requirements in Obese Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating propofol and remifentanil requirements in obese patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PROPOFOL (Propofol)
• Remifentanil (remifentanil)

Snippet

Sponsor: Hopital Foch | Conditions: Anesthesia, Obesity | Phase 4 | Status: TERMINATED